Compare ALEMBIC LTD with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs DR. REDDYS LAB - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD DR. REDDYS LAB ALEMBIC LTD/
DR. REDDYS LAB
 
P/E (TTM) x 73.8 17.4 423.8% View Chart
P/BV x 2.6 3.3 78.6% View Chart
Dividend Yield % 0.4 0.7 54.9%  

Financials

 ALEMBIC LTD   DR. REDDYS LAB
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
DR. REDDYS LAB
Mar-19
ALEMBIC LTD/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs722,875 2.5%   
Low Rs341,888 1.8%   
Sales per share (Unadj.) Rs4.7930.2 0.5%  
Earnings per share (Unadj.) Rs6.1117.4 5.2%  
Cash flow per share (Unadj.) Rs6.2185.8 3.4%  
Dividends per share (Unadj.) Rs0.2020.00 1.0%  
Dividend yield (eoy) %0.40.8 45.0%  
Book value per share (Unadj.) Rs40.7844.4 4.8%  
Shares outstanding (eoy) m267.03166.07 160.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x11.32.6 440.0%   
Avg P/E ratio x8.720.3 42.8%  
P/CF ratio (eoy) x8.512.8 66.1%  
Price / Book Value ratio x1.32.8 46.2%  
Dividend payout %3.317.0 19.2%   
Avg Mkt Cap Rs m14,139395,496 3.6%   
No. of employees `000NA22.0 0.0%   
Total wages/salary Rs m20733,562 0.6%   
Avg. sales/employee Rs ThNM7,032.8-  
Avg. wages/employee Rs ThNM1,527.9-  
Avg. net profit/employee Rs ThNM887.7-  
INCOME DATA
Net Sales Rs m1,255154,482 0.8%  
Other income Rs m3703,375 11.0%   
Total revenues Rs m1,625157,857 1.0%   
Gross profit Rs m11131,782 0.3%  
Depreciation Rs m3811,348 0.3%   
Interest Rs m2889 0.2%   
Profit before tax Rs m44222,920 1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,212438 276.7%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m243,858 0.6%   
Profit after tax Rs m1,63019,500 8.4%  
Gross profit margin %8.920.6 43.0%  
Effective tax rate %5.416.8 32.2%   
Net profit margin %129.812.6 1,028.7%  
BALANCE SHEET DATA
Current assets Rs m1,867111,101 1.7%   
Current liabilities Rs m59158,973 1.0%   
Net working cap to sales %101.633.7 301.2%  
Current ratio x3.21.9 167.6%  
Inventory Days Days9479 118.8%  
Debtors Days Days7494 78.1%  
Net fixed assets Rs m1,791101,245 1.8%   
Share capital Rs m534830 64.3%   
"Free" reserves Rs m10,324139,406 7.4%   
Net worth Rs m10,858140,236 7.7%   
Long term debt Rs m4122,000 0.2%   
Total assets Rs m11,591224,656 5.2%  
Interest coverage x260.926.8 974.1%   
Debt to equity ratio x00.2 2.4%  
Sales to assets ratio x0.10.7 15.7%   
Return on assets %14.19.1 155.1%  
Return on equity %15.013.9 108.0%  
Return on capital %15.214.9 101.6%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1988,673 0.0%   
Fx outflow Rs m26419,104 1.4%   
Net fx Rs m-24469,569 -0.4%   
CASH FLOW
From Operations Rs m23628,704 0.8%  
From Investments Rs m-224-7,727 2.9%  
From Financial Activity Rs m-27-21,326 0.1%  
Net Cashflow Rs m-15-314 4.7%  

Share Holding

Indian Promoters % 64.0 25.5 251.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 5.4 3.7%  
FIIs % 9.7 35.3 27.5%  
ADR/GDR % 0.0 18.5 -  
Free float % 26.1 15.3 170.6%  
Shareholders   54,701 75,885 72.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Dec 13, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - ELDER PHARMA COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS